A Study of LNK01001 Capsule in Patients With Ankylosing Spondylitis

Clinical trial NCT06085534 · COMPLETED

Trial details

NCT number: NCT06085534
Sponsor: Lynk Pharmaceuticals Co., Ltd
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ankylosing Spondylitis

Start date: 2022-01-06
Primary completion: 2022-12-06
Enrollment: 177

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.